Skip to main content
. 2015 Nov 25;24(5):2309–2316. doi: 10.1007/s00520-015-3036-7

Fig. 1.

Fig. 1

Odds ratios for febrile neutropenia among patients receiving pegfilgrastim prophylaxis on same day as chemotherapy versus days 2–4 from chemotherapy completion